Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-25-015264

Director sold 2,000 shares at $243.47 ($486,940)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
De Witte Jan Director 2025-05-20 Sale 10b5-1 −2,000 $243.47 $486,940 5,806 D
Open-market sales · 2,000 sh · avg $243.47 · $486,940
Loading xslF345X05/form4.xml…